Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Decitabine: Phase I

In a 15-patient dose-ranging study in Canada, the median survival for patients

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE